🩺What is Sarcopenia?
The G8 (Geriatric 8) screening tool was developed by the French National Geriatric Oncology Program to screen for frailty in older adults with cancer. It consists of 8 items covering: food intake decline due to digestive problems/decreased appetite/chewing or swallowing difficulties (0-3 points), weight loss in the past 3 months (0-3 points), mobility (0-2 points), neuropsychological problems including dementia or depression (0-2 points), BMI (0-3 points), number of prescription medications per day (0-1 point), self-rated health compared to peers (0-2 points), and age (0-1 point). Total scores range from 0 (most impaired) to 17 (least impaired). A score of ≤14 is considered abnormal and indicates the need for comprehensive geriatric assessment (CGA). The G8 has been validated in multiple international cohorts and demonstrates sensitivity of 76-92% for detecting frailty. The G8 is the most widely used geriatric screening tool in oncology and is recommended by the International Society of Geriatric Oncology (SIOG) and the American Society of Clinical Oncology (ASCO) guidelines for geriatric assessment in older adults with cancer.
📊Clinical Assessment & Risk Scoring
Healthcare professionals use these validated clinical calculators, diagnostic scales, and risk scoring systems to assess the severity, prognosis, or therapeutic dosing requirements for Sarcopenia:
G8 — Geriatric 8 Screening
The Geriatric 8 (G8) screening tool is an 8-item validated instrument designed to identify older patients who may benefit from comprehensive geriatric assessment (CGA). It is widely used in geriatric oncology to detect frailty.
MNA-SF — Mini Nutritional Assessment (Short Form)
The Mini Nutritional Assessment Short Form (MNA-SF) is a validated 6-item screening tool for malnutrition risk in older adults. It is widely used in geriatric medicine, long-term care, and hospital settings to identify patients requiring nutritional intervention.
🧬Diagnostic Logic & Scoring Breakdown
The G8 total score is calculated by summing points from 8 items assessing different aspects of geriatric health. Each item has specific response categories with varying point values. Item 1: Has food intake declined due to appetite loss, digestive problems, or chewing/swallowing difficulties? (0 = severe decrease, 1 = moderate decrease, 2 = no decrease). Item 2: Weight loss in the past 3 months (0 = >3 kg loss, 1 = does not know, 2 = 1-3 kg loss, 3 = no loss). Item 3: Mobility (0 = bed/chair bound, 1 = able to get out of bed/chair but does not go out, 2 = goes out). Item 4: Neuropsychological problems (0 = severe dementia/depression, 1 = mild dementia/depression, 2 = no problems). Item 5: BMI (0 = <19, 1 = 19-21, 2 = 21-23, 3 = ≥23). Item 6: Number of medications (0 = ≥3, 1 = 0-2). Item 7: Self-rated health compared to peers (0 = not as good, 1 = does not know, 2 = as good). Item 8: Age (0 = ≥85, 1 = <85). A total score ≤14 indicates that the patient would benefit from comprehensive geriatric assessment.
📢Clinical Significance & Implications
The G8 is the most widely used geriatric screening tool in oncology, recommended by SIOG and ASCO guidelines for all older adults (≥70 years) with cancer. It identifies patients who would benefit from comprehensive geriatric assessment (CGA), which has been shown to improve treatment tolerance, reduce toxicity, and improve quality of life in older cancer patients. The G8 has a high negative predictive value (95%) for frailty, meaning a normal score reliably identifies patients who do not need CGA. The G8 takes approximately 5 minutes to complete and can be administered by any healthcare professional.
💡 Clinical Assessment Scenario Example
A 78-year-old woman with recently diagnosed stage II colorectal cancer is being evaluated for treatment planning. G8 assessment: Food intake: moderate decrease due to chemotherapy-related nausea (1 point), Weight loss: 2 kg in past 3 months (2 points), Mobility: goes out independently (2 points), Neuropsych: no problems (2 points), BMI: 21.5 (2 points), Medications: 4 prescription medications (0 points), Self-rated health: not as good as peers (0 points), Age: <85 (1 point). Total G8 score = 1+2+2+2+2+0+0+1 = 10/17. This abnormal score (≤14) indicates the patient would benefit from comprehensive geriatric assessment before initiating cancer treatment to optimize outcomes and minimize toxicity.
💊Common Medications & Interventions
The following pharmacological therapies and substances are commonly referenced or adjusted based on the clinical assessment of Sarcopenia:
⚠️Clinical Assessment Pitfalls
❌ Mistake: Using G8 as a substitute for comprehensive geriatric assessment (CGA)
✅ Correction: G8 is a screening tool, not a comprehensive assessment. Abnormal G8 (≤14) triggers referral for CGA, not a diagnosis of frailty.
❌ Mistake: Not knowing patient's weight loss amount and scoring as 0
✅ Correction: If weight loss is unknown, score as 1 point ("does not know"). Do not default to 0 or 3. Weight estimation by family or records may help.
❌ Mistake: Using MNA-SF without the full MNA follow-up for at-risk patients
✅ Correction: MNA-SF is a screening tool. Patients scoring 8-11 (at risk) should receive the full 18-item MNA assessment for comprehensive evaluation.
❌ Mistake: Assuming normal MNA-SF rules out all nutritional problems
✅ Correction: MNA-SF screens for malnutrition risk, not all nutritional disorders. Patients with specific nutritional concerns (e.g., vitamin deficiencies, sarcopenia) may need additional evaluation even with normal MNA-SF.
🚑When to Seek Medical Attention
This reference supports clinical assessment of Sarcopenia; it does not replace urgent evaluation. Seek prompt in-person medical care if symptoms are severe, rapidly worsening, or life-threatening, or if you are unsure about a diagnosis or treatment plan. Patients should always consult their physician before starting or changing any therapy.
❓Frequently Asked Questions
Q: What is comprehensive geriatric assessment (CGA)?
Comprehensive Geriatric Assessment (CGA) is a multidimensional, multidisciplinary process that evaluates an older person's medical, functional, cognitive, psychological, and social status. It typically involves a team including a geriatrician, nurse, pharmacist, physical therapist, occupational therapist, and social worker. CGA has been shown to improve outcomes including reduced hospitalizations, improved functional status, and better quality of life.
Q: Who should be screened with G8?
The G8 is recommended for all older adults aged 70 years and above, particularly those being evaluated for cancer treatment or undergoing geriatric care. Many oncology guidelines recommend G8 screening for all patients aged 70+ at initial consultation.
Q: What is the difference between MNA-SF and full MNA?
The MNA-SF is a 6-item screening tool (5 minutes) that identifies patients needing further assessment. The full MNA adds 12 additional items (15 minutes total) covering dietary history, living environment, medications, and mid-arm/calf circumference for comprehensive nutritional assessment.
Q: How often should MNA-SF be performed?
For community-dwelling older adults, MNA-SF screening is recommended annually or whenever clinical concern arises. For hospitalized patients, screening should be performed on admission and repeated weekly. For long-term care residents, screening every 3 months is recommended.
📚Evidence-Based References
Medically Reviewed By
Dr. Ahmed Abdelrahman
MD, MSc | Internal Medicine
Dr. Ahmed is a healthcare management consultant with over 15 years of experience in clinical practice and medical education.